Form 4: Achieve Life Sciences CEO Richard Stewart Acquires 10,000 Shares
SEC Form 4
Richard Alistair Stewart, CEO of Achieve Life Sciences, purchased 10,000 shares of common stock on March 17, 2025.
Summary
- On March 17, 2025, Richard Alistair Stewart, the CEO of Achieve Life Sciences, acquired 10,000 shares of common stock at a price of $2.8598 per share.
- Following this transaction, Stewart directly owns 60,876 shares of Achieve Life Sciences common stock.
- Stewart also indirectly owns 359 shares through his spouse and 882 shares through Ricanto Limited, where he is a principal owner.
- In January 2025, Stewart relinquished a stock option to purchase 67,500 shares granted on January 13, 2025, as per an agreement with the issuer.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock purchase by the CEO. No indication of positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company executives and directors.
Stakeholder Impact
- The purchase of shares by the CEO could be perceived positively by shareholders, signaling confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| January 2025 | Richard Stewart relinquished stock option to purchase 67,500 shares. |
| 01/13/2025 | Date of original stock option grant for 67,500 shares. |
| 03/17/2025 | Richard Stewart purchased 10,000 shares of common stock. |
| 03/19/2025 | Date of signature on the Form 4 filing. |
Keywords
ACHV, Achieve Life Sciences, Richard Stewart, CEO, stock purchase, Form 4, insider trading, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.